Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1984 | 1 |
2012 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Interferons in the treatment of human cancer.
J Clin Oncol. 1984 Apr;2(4):336-52. doi: 10.1200/JCO.1984.2.4.336.
J Clin Oncol. 1984.
PMID: 6323641
Review.
Progress with the clinical application of interferons to cancer has been slow and complicated by the need for attention to a new spectrum of therapeutic and toxic effects manifest by the interferons. This summary of current phase I and II trial results with the interferons …
Progress with the clinical application of interferons to cancer has been slow and complicated by the need for attention to a new spectrum of …
Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray.
Turner BM, Cagle PT, Sainz IM, Fukuoka J, Shen SS, Jagirdar J.
Turner BM, et al.
Arch Pathol Lab Med. 2012 Feb;136(2):163-71. doi: 10.5858/arpa.2011-0320-OA.
Arch Pathol Lab Med. 2012.
PMID: 22288963
Free article.
CONTEXT: Differentiation of non-small cell carcinoma into histologic types is important because of new, successful therapies that target lung adenocarcinoma (ACA). TTF-1 is a favored marker for lung ACA but has limited sensitivity and specificity. ...DESIGN: Immunoh …
CONTEXT: Differentiation of non-small cell carcinoma into histologic types is important because of new, successful therapies that tar …
Item in Clipboard
Cite
Cite